Lionco(603669.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Lionco
603669.SH
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China.
2.805 T
603669.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking203/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-24.98%E
    • Profit Margin-47.83%E
    • Gross Margin28.85%C
  • Growth ScoreD
    • Revenue YoY1.66%C
    • Net Profit YoY-28.74%D
    • Total Assets YoY-8.91%E
    • Net Assets YoY-17.03%E
  • Cash ScoreC
    • Cash Flow Margin86.52%C
    • OCF YoY1.66%C
  • Operating ScoreD
    • Turnover0.31D
  • Debt ScoreC
    • Gearing Ratio44.44%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Lionco: Subsidiary Lionco Pharmaceutical's product, injectable cefazolin sodium, is expected to be selected for national centralized drug procurement

    Zhitong·
    SH
    603669
    -0.68%
    Zhitong·
    SH
    603669
    -0.68%

    The A-share CRO concept sector has seen a surge, with Lionco hitting the daily limit, MeHow rising over 10%, and Haoyuan Pharmaceutical, Boji Pharmaceutical, Medicilon, Sun-Novo, and Heyuan Biotechnology also following suit

    Zhitong·
    SH
    688202
    -1.09%
    SH
    688621
    -0.46%
    SH
    603669
    -0.68%
    Zhitong·
    SH
    688202
    -1.09%
    SH
    688621
    -0.46%
    SH
    603669
    -0.68%

    The chemical pharmaceutical sector continues to rise, with SUNHERE and Lionco hitting the daily limit

    Zhitong·
    SH
    603669
    -0.68%
    SZ
    300452
    -1.92%
    Zhitong·
    SH
    603669
    -0.68%
    SZ
    300452
    -1.92%

    CRO concept stocks partially rose, Lionco surged to the daily limit

    Zhitong·
    SZ
    301096
    +0.21%
    SH
    688602
    -0.13%
    SH
    603127
    +1.17%
    Zhitong·
    SZ
    301096
    +0.21%
    SH
    688602
    -0.13%
    SH
    603127
    +1.17%

    Lionco: Wholly-owned subsidiary receives clinical trial approval notice for acetazolamide sustained-release capsule medication

    Zhitong·
    SH
    603669
    -0.68%
    Zhitong·
    SH
    603669
    -0.68%
    © 2026 Longbridge｜Disclaimer